Stem Cell Sources for Vascular Tissue Engineering and Regeneration

Bajpai, Vivek K.; Andreadis, Stelios T.

doi:10.1089/ten.teb.2011.0264

Cited by 95

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Stem Cell Sources for Vascular Tissue Engineering and Regeneration

Bajpai, Vivek K., Andreadis, Stelios T.·2012·Tissue Engineering Part B: Reviews

DOI 10.1089/ten.teb.2011.0264

Open this paper in CoChat — free account

Abstract

This review focuses on the stem cell sources with the potential to be used in vascular tissue engineering and to promote vascular regeneration. The first clinical studies using tissue-engineered vascular grafts are already under way, supporting the potential of this technology in the treatment of cardiovascular and other diseases. Despite progress in engineering biomaterials with the appropriate mechanical properties and biological cues as well as bioreactors for generating the correct tissue microenvironment, the source of cells that make up the vascular tissues remains a major challenge for tissue engineers and physicians. Mature cells from the tissue of origin may be difficult to obtain and suffer from limited proliferative capacity, which may further decline as a function of donor age. On the other hand, multipotent and pluripotent stem cells have great potential to provide large numbers of autologous cells with a great differentiation capacity. Here, we discuss the adult multipotent as well as embryonic and induced pluripotent stem cells, their differentiation potential toward vascular lineages, and their use in engineering functional and implantable vascular tissues. We also discuss the associated challenges that need to be addressed in order to facilitate the transition of this technology from the bench to the bedside.

Integrity signals

Registry

Crossref · 10.1089/ten.teb.2011.0264

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis
Cotsarelis, G., Sun, T.-T., & Lavker, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90696-c · Cited by 2,276
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734
Generation of induced pluripotent stem cells from human blood
Loh, Y.-H., Agarwal, S., Park, I.-H., Urbach, A., Huo, H., Heffner, G. C., Kim, K., Miller, J. D., Ng, K., & Daley, G. Q. (2009) · Blood · doi:10.1182/blood-2009-02-204800 · Cited by 626

Show all 8 references

Research works printed but not linked: 294

10.1016/S0003-4975(03)01331-6 · DOI
10.1378/chest.122.6.2075 · DOI
10.1055/s-2003-43078 · DOI
10.1056/NEJM199601253340402 · DOI
10.1067/mva.2001.111729 · DOI
10.1177/096721099500300304 · DOI
10.1097/00000658-198401000-00011 · DOI
10.1016/S0741-5214(97)70003-X · DOI
10.1016/S0741-5214(97)70305-7 · DOI
10.1111/j.1540-8191.2008.00623.x · DOI
10.1016/0741-5214(90)90262-9 · DOI
10.1161/CIRCULATIONAHA.104.512905 · DOI
10.1046/j.1525-1594.2002.06841.x · DOI
Veith F.J., , Moss C.M., , Sprayregen S., , Montefusco C. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. Surgery, 85:253. 1979.
10.1016/S0022-5223(19)36328-7 · DOI
10.1016/j.ejcts.2009.02.013 · DOI
10.1016/S0022-5223(19)39420-6 · DOI
10.1080/00015458.1999.12098497 · DOI
10.1016/0741-5214(86)90073-X · DOI
10.1067/mva.2001.112806 · DOI
10.1097/00000658-197201000-00018 · DOI
10.1016/j.ejvs.2006.01.006 · DOI
10.1016/0741-5214(87)90148-0 · DOI
10.1016/j.jsb.2003.08.002 · DOI · Paper page
Bader A., , Steinhoff G., , Strobl K., , Schilling T., , Brandes G., , Mertsching H. et al. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation, 70:7. 2000.
10.1038/nm0901-1035 · DOI
10.1016/j.athoracsur.2005.08.083 · DOI
10.1016/j.biomaterials.2009.09.049 · DOI
10.1016/S1350-4533(02)00010-3 · DOI
10.1016/j.biomaterials.2010.09.006 · DOI · Paper page
10.1080/089419301753435693 · DOI
10.1089/ten.tea.2008.0526 · DOI
10.1016/0022-4804(89)90050-4 · DOI
10.1038/15062 · DOI
10.1089/ten.tea.2010.0109 · DOI
L'Heureux N., , Paquet S., , Labbe R., , Germain L., , Auger F.A. A completely biological tissue-engineered human blood vessel. FASEB J, 12:47. 1998.
10.1096/fj.00-0283com · DOI
10.1056/NEJMc071536 · DOI
10.1016/S0140-6736(09)60248-8 · DOI
10.1126/science.284.5413.489 · DOI
Kannan R.Y., , Sales K.M., , Salacinski H.J., , Butler P.E., , Seifalian A.M. Endothelialisation of poly (carbonate-siloxane-urea) urethane. Med J Malaysia, 59,Suppl B:107. 2004.
10.1016/j.jtcvs.2007.06.039 · DOI
10.1097/SLA.0b013e318184dcbd · DOI
10.1016/S0142-9612(02)00608-7 · DOI
10.1126/scitranslmed.3001426 · DOI
10.1126/science.2934816 · DOI
10.1114/1.275 · DOI
10.1114/1.1415522 · DOI
10.1089/107632703768247359 · DOI
10.1006/excr.1996.0065 · DOI
10.1002/jbm.a.10589 · DOI
10.1016/S0945-053X(03)00052-0 · DOI
10.1016/j.biomaterials.2010.09.019 · DOI
10.1016/j.cardiores.2007.04.018 · DOI
10.1152/ajpheart.00479.2004 · DOI
10.1016/0741-5214(93)90150-K · DOI
10.1097/00002480-199407000-00027 · DOI
10.1016/S0022-5223(98)70315-0 · DOI
10.1016/j.jtcvs.2009.09.057 · DOI
10.1056/NEJM200102153440717 · DOI
10.1016/j.jtcvs.2004.12.047 · DOI
10.1161/01.CIR.0000092165.32213.61 · DOI
10.1016/S0142-9612(02)00506-9 · DOI
10.1114/1.1558031 · DOI
10.1002/jbm.a.10589 · DOI
10.1016/S0140-6736(05)66735-9 · DOI
10.1097/01.sla.0000154268.12239.ed · DOI
10.1007/s10439-006-9101-0 · DOI
10.1073/pnas.0704581104 · DOI
10.1089/ten.tea.2009.0427 · DOI
10.1016/j.biomaterials.2010.02.051 · DOI
10.3727/000000004773301762 · DOI
10.1172/JCI28184 · DOI
10.1161/CIRCRESAHA.108.178590 · DOI
10.1182/blood-2006-11-055566 · DOI
10.1096/fj.07-087924 · DOI
10.1016/j.jss.2009.08.001 · DOI
10.1073/pnas.0604850103 · DOI
10.1159/000113407 · DOI
10.1111/j.1743-6109.2008.01172.x · DOI
10.1016/j.mvr.2010.05.006 · DOI
10.1089/scd.2010.0152 · DOI
10.1016/j.jss.2008.06.029 · DOI
10.1016/j.bbrc.2005.04.135 · DOI
10.1093/cvr/cvn059 · DOI
10.1089/ten.tea.2009.0833 · DOI
10.2353/ajpath.2006.051170 · DOI
10.1002/jcb.21078 · DOI
10.1016/j.placenta.2010.11.003 · DOI
10.1016/S1016-8478(23)13006-8 · DOI
10.1097/00007890-197404000-00001 · DOI
10.1182/blood.V98.9.2615 · DOI
10.1073/pnas.97.7.3213 · DOI
10.1159/000071150 · DOI · Paper page
10.1016/S0301-472X(03)00110-3 · DOI
10.1097/01.TP.0000045055.63901.A9 · DOI
10.1182/blood-2005-07-2657 · DOI · Paper page
10.1182/blood.V99.10.3838 · DOI · Paper page
10.1182/blood-2004-02-0586 · DOI
10.1016/S0301-472X(02)00869-X · DOI
10.1006/exnr.2000.7389 · DOI
10.1007/978-1-4615-0063-6_9 · DOI
10.1161/hc0102.101442 · DOI
10.1080/14653240600855905 · DOI · Paper page
10.1182/blood.V98.8.2396 · DOI
Friedenstein A.J., , Gorskaja J.F., , Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol, 4:267. 1976.
in ’t Anker P.S., , Noort W.A., , Scherjon S.A., , Kleijburg-van der Keur C., , Kruisselbrink A.B., , van Bezooijen R.L. et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica, 88:845. 2003.
10.1091/mbc.e02-02-0105 · DOI
10.1002/dvdy.22008 · DOI
10.1038/nature08792 · DOI
10.1634/stemcells.2007-1122 · DOI · Paper page
10.1016/j.jvs.2007.12.038 · DOI
10.1089/107632701300062859 · DOI · Paper page
10.1089/ten.2006.0275 · DOI
10.1091/mbc.e04-10-0949 · DOI
10.1097/01.PRS.0000055043.62589.05 · DOI
10.1242/jcs.01264 · DOI
10.1016/S0006-291X(02)00469-2 · DOI
10.1016/j.bbrc.2004.12.158 · DOI · Paper page
10.1089/ten.tec.2009.0208 · DOI
10.1016/j.bbrc.2006.01.072 · DOI
10.1007/s10047-009-0455-6 · DOI
10.1111/j.1365-2141.2005.05409.x · DOI
10.1182/blood-2009-11-252650 · DOI
10.1161/01.CIR.0000114522.38265.61 · DOI
10.1161/01.CIR.0000135466.16823.D0 · DOI
10.1016/j.jss.2010.04.025 · DOI
10.1111/j.1432-0436.2006.00110.x · DOI
10.1634/stemcells.2006-0428 · DOI
10.1126/science.1092436 · DOI · Paper page
10.1038/nbt950 · DOI · Paper page
10.1634/stemcells.2008-0721 · DOI
10.1038/jid.2009.322 · DOI
10.1073/pnas.0508440102 · DOI
10.1016/j.bbrc.2008.08.166 · DOI
10.1073/pnas.0501263102 · DOI
10.1111/j.1365-2133.1969.tb12855.x · DOI
10.1038/311560a0 · DOI
10.1111/j.0906-6705.2003.00161.x · DOI
10.1111/j.0022-202X.2005.23734.x · DOI
10.1089/scd.2006.15.49 · DOI
10.1242/jcs.00060 · DOI
10.1016/j.scr.2011.07.003 · DOI
10.1089/ten.tea.2010.0109 · DOI
10.1038/jid.1965.42 · DOI
10.1038/46938 · DOI
10.1155/2009/789526 · DOI
10.1002/stem.5530080708 · DOI
Broxmeyer H.E., , Kurtzberg J., , Gluckman E., , Auerbach A.D., , Douglas G., , Cooper S. et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells, 17:313. 1991.
10.1046/j.1365-2141.2000.01986.x · DOI
10.1084/jem.20040440 · DOI
10.1080/14653240600941549 · DOI
10.1182/blood-2006-08-043471 · DOI
10.2478/v10042-008-0036-1 · DOI
10.4103/0973-6247.59386 · DOI
10.1634/stemcells.22-4-625 · DOI
10.1634/stemcells.2005-0342 · DOI · Paper page
Fan C.L., , Li Y., , Gao P.J., , Liu J.J., , Zhang X.J., , Zhu D.L. Differentiation of endothelial progenitor cells from human umbilical cord blood CD 34+ cells in vitro. Acta Pharmacol Sin, 24:212. 2003.
10.1007/s00277-004-0988-y · DOI
10.1161/01.RES.0000090624.04507.45 · DOI
10.3109/14653240903300658 · DOI
10.1111/j.1600-0463.2010.02693.x · DOI
10.1111/j.1745-7254.2007.00519.x · DOI
10.1016/j.ejcts.2003.12.038 · DOI
10.1634/stemcells.2004-0166 · DOI
10.1042/bst019029s · DOI
10.1016/S0003-4975(02)03910-3 · DOI
10.1002/term.107 · DOI
10.1053/j.gastro.2007.12.024 · DOI
10.1634/stemcells.2006-0286 · DOI
Conconi M.T., , Burra P., , Di Liddo R., , Calore C., , Turetta M., , Bellini S. et al. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med, 18:1089. 2006.
10.1080/14653240801891667 · DOI
10.1634/stemcells.2007-1028 · DOI
10.1016/0012-1606(86)90234-4 · DOI
10.1002/mus.880080307 · DOI
10.1083/jcb.200108150 · DOI
10.1177/000313489906500106 · DOI
10.1016/j.biomaterials.2007.10.044 · DOI
10.1126/science.275.5302.964 · DOI · Paper page
10.1182/blood.V92.2.362 · DOI
10.1161/01.RES.85.3.221 · DOI
10.1093/emboj/18.14.3964 · DOI
10.1161/01.RES.88.2.167 · DOI
10.1111/j.1365-2125.2009.03486.x · DOI
10.1182/blood-2004-04-1396 · DOI
10.1038/7434 · DOI
10.1182/blood.V95.3.952.003k27_952_958 · DOI
10.1016/j.jacc.2003.07.025 · DOI
10.1016/j.yjmcc.2010.07.009 · DOI
10.1016/j.mvr.2010.01.012 · DOI
10.1038/mt.2011.18 · DOI
10.1096/fj.10-162040 · DOI
10.1161/CIRCULATIONAHA.109.930404 · DOI
10.1016/j.jtcvs.2010.08.012 · DOI
10.1182/blood-2005-04-1509 · DOI
10.1016/j.jacc.2004.12.074 · DOI · Paper page
10.1111/j.1476-5381.2009.00450.x · DOI
10.1016/j.pharmthera.2010.10.005 · DOI
10.1634/stemcells.22-5-675 · DOI
10.1016/j.mad.2007.12.002 · DOI · Paper page

200 of 294 shown

Bioprinting for vascular and vascularized tissue biofabrication
Datta, P., Ayan, B., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.035 · Cited by 431
Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges
Chalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66

See all 95

Authors: Bajpai, V. K., & Andreadis, S. T.
Affiliations: The State University of New York
Venue: Tissue Engineering Part B: Reviews
Publisher: SAGE Publications
Published: 2012-07-03
Volume: 18
Issue: 5
Pages: 405-425
ISSN: 1937-3368
1937-3376
DOI: 10.1089/ten.teb.2011.0264
Cited by: 95
References: 8
Language: en
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page: CoChat. (2026). Citation check: Stem Cell Sources for Vascular Tissue Engineering and Regeneration. https://app.cochat.ai/papers/10.1089/ten.teb.2011.0264
The paper: Bajpai, V. K., & Andreadis, S. T. (2012). Stem Cell Sources for Vascular Tissue Engineering and Regeneration. Tissue Engineering Part B: Reviews. https://doi.org/10.1089/ten.teb.2011.0264

Stem Cell Sources for Vascular Tissue Engineering and Regeneration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks

How to cite